Endonovo Therapeutics, Inc.
Balance Sheet
| Line Item | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $5.7K | $8.5K | $86.0K | $13.4K | $2.6K | $5.3K | $178 | $18.9K |
| Accounts Receivable | $7.1K | $9.4K | $7.5K | $942 | $942 | $941 | $3.1K | $22.7K |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $62.5K | $38.7K | $124.2K | $46.2K | $8.6K | $9.6K | $17.9K | $62.6K |
| Property, Plant & Equipment | — | — | — | $1.6K | $2.5K | $3.4K | $4.3K | $5.9K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $2.1M | $2.2M | $2.4M | $2.6M | $2.7M | $2.9M | $3.0M | $3.2M |
| Total Assets | $2.1M | $2.3M | $2.5M | $2.6M | $2.7M | $2.9M | $3.1M | $3.3M |
| Liabilities | ||||||||
| Accounts Payable | $753.0K | $711.2K | $721.8K | $700.9K | $762.2K | $609.4K | $576.7K | $599.5K |
| Total Current Liabilities | $20.3M | $19.2M | $18.3M | $16.8M | $15.3M | $14.9M | $14.1M | $23.6M |
| Long-Term Debt | $6.8M | $6.7M | $6.8M | $6.8M | $6.2M | $6.2M | $6.1M | $6.9M |
| Total Liabilities | $20.4M | $19.3M | $18.5M | $17.0M | $15.5M | $15.1M | $14.2M | $23.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-58.8M | $-57.3M | $-56.0M | $-53.3M | $-51.3M | $-50.2M | $-48.6M | $-52.9M |
| Total Stockholders' Equity | $-18.2M | $-17.0M | $-16.0M | $-14.4M | $-12.8M | $-12.2M | $-11.1M | $-20.5M |